Atrial Fibrillation (also known as Afib) is a quivering or irregular heartbeat that can lead to blood clots, stroke, heart failure and other heart related complications. Previously, the only option to prevent a stroke with atrial fibrillation was taking blood thinners such as warfarin, eliquis, etc. and other medication to help control the heart rate during atrial fibrillation. Not anymore.
WATCHMAN™ (catheter-based left atrial appendage closure) is a new procedure for patients suffering from atrial fibrillation (Afib) that can help reduce the risk of stroke and eliminate the need for blood thinning medications.
How it Works:
The WATCHMAN™ procedure begins with a small incision in the upper leg, where a catheter is inserted into the body through the femoral vein. Next, the WATCHMAN™ device is guided to the left side of the heart, and then to the left atrial appendage – where the device will be placed. The area is measured, and the correct sized device is precisely placed, and anchored. Once in place, the device will seal off the left atrial appendage, preventing future blood clots.
Most WATCHMAN™ patients will stay one night in the hospital and continue on blood thinners for 45 days while tissue begins to grow over the device to form a barrier against blood clots.